AU2002223841A1 - Method of separating extra-chromosomal dna from other cellular components - Google Patents

Method of separating extra-chromosomal dna from other cellular components

Info

Publication number
AU2002223841A1
AU2002223841A1 AU2002223841A AU2384102A AU2002223841A1 AU 2002223841 A1 AU2002223841 A1 AU 2002223841A1 AU 2002223841 A AU2002223841 A AU 2002223841A AU 2384102 A AU2384102 A AU 2384102A AU 2002223841 A1 AU2002223841 A1 AU 2002223841A1
Authority
AU
Australia
Prior art keywords
chromosomal dna
cellular components
separating extra
extra
separating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223841A
Inventor
Henry Charlton
Alex Eon-Duval
Robert Macduff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002223841A1 publication Critical patent/AU2002223841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002223841A 2000-11-21 2001-11-20 Method of separating extra-chromosomal dna from other cellular components Abandoned AU2002223841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0028361.4A GB0028361D0 (en) 2000-11-21 2000-11-21 Method of separating extra chromosomal dna from other cellular components
GB0028361.4 2000-11-21
PCT/GB2001/005114 WO2002042317A2 (en) 2000-11-21 2001-11-20 Method of separating extra-chromosomal dna from other cellular components

Publications (1)

Publication Number Publication Date
AU2002223841A1 true AU2002223841A1 (en) 2002-06-03

Family

ID=9903579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223841A Abandoned AU2002223841A1 (en) 2000-11-21 2001-11-20 Method of separating extra-chromosomal dna from other cellular components

Country Status (13)

Country Link
US (1) US20040076980A1 (en)
EP (1) EP1335926B1 (en)
JP (1) JP4422406B2 (en)
AR (1) AR031482A1 (en)
AT (1) ATE364613T1 (en)
AU (1) AU2002223841A1 (en)
CA (1) CA2428885A1 (en)
DE (1) DE60128945T2 (en)
ES (1) ES2287189T3 (en)
GB (1) GB0028361D0 (en)
MY (1) MY129812A (en)
TW (1) TWI289142B (en)
WO (1) WO2002042317A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107634D0 (en) * 2001-03-27 2001-05-16 Fermentas Ab Nucleic acid purification
EP1856262B1 (en) * 2005-01-31 2012-08-15 Merck Sharp & Dohme Corp. Upstream and a downstream purification process for large scale production of plasmid dna
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
ES2734973T3 (en) 2009-12-01 2019-12-13 Translate Bio Inc Administration of mRNA for the increase of proteins and enzymes in human genetic diseases
AT509622A1 (en) * 2010-04-08 2011-10-15 Greiner Bio One Gmbh METHOD AND KIT FOR THE SEPARATION OF VIRAL AND PROKARYONTIC FROM EUKARYONTIC NUCLEIC ACIDS
US10597652B2 (en) * 2011-03-29 2020-03-24 Phynexus, Inc. Methods and devices for nucleic acid purification
US10883100B2 (en) 2011-03-29 2021-01-05 Phynexus, Inc Devices and methods for plasmid purification
US11274292B2 (en) 2011-03-29 2022-03-15 Phynexus, Inc. Devices and methods for plasmid purification
EP2717893B1 (en) 2011-06-08 2019-05-08 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mrna delivery
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
US9107960B2 (en) 2012-12-13 2015-08-18 Immunimedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
KR102356017B1 (en) 2012-12-13 2022-01-27 이뮤노메딕스, 인코오포레이티드 Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
EP3467108B1 (en) 2013-03-14 2024-05-22 Translate Bio, Inc. Methods for purification of messenger rna
IL290953B2 (en) 2013-03-14 2024-01-01 Ethris Gmbh Cftr mrna compositions and related methods and uses
CA2914438C (en) * 2013-07-23 2022-06-14 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
MX2016005237A (en) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Mrna therapy for argininosuccinate synthetase deficiency.
EP3060258A1 (en) 2013-10-22 2016-08-31 Shire Human Genetic Therapies, Inc. Mrna therapy for phenylketonuria
CN117402871A (en) 2014-04-25 2024-01-16 川斯勒佰尔公司 Method for purifying messenger RNA
US10266605B2 (en) 2016-04-27 2019-04-23 Immunomedics, Inc. Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
EA201991747A1 (en) 2017-02-27 2020-06-04 Транслейт Био, Инк. NEW CODON-OPTIMIZED CFTR mRNA
CA3050332A1 (en) 2017-03-27 2018-10-04 Immunomedics, Inc. Treatment of trop-2 expressing triple negative breast cancer with sacituzumab govitecan and a rad51 inhibitor
EP3606964A4 (en) 2017-04-03 2020-12-09 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CA3063531A1 (en) 2017-05-16 2018-11-22 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
US11174500B2 (en) 2018-08-24 2021-11-16 Translate Bio, Inc. Methods for purification of messenger RNA
WO2020160087A1 (en) * 2019-01-29 2020-08-06 Flagship Pioneering Innovations V, Inc. Methods of separating long polynucleotides from a composition
CN116790578B (en) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 Production process for rapidly purifying plasmid based on alkaline cracking method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
EP0880536B2 (en) * 1996-02-06 2015-08-05 Roche Diagnostics GmbH Process for preparing purified nucleic acid and the use thereof
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6011148A (en) * 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
EP0853123A1 (en) * 1997-01-10 1998-07-15 Roche Diagnostics GmbH Purification of DNA by 'cross-flow-filtration'
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
US6268492B1 (en) * 1998-08-10 2001-07-31 Chiron Corporation Methods for purifying non-chromosomal nucleic acid molecules from cells
CA2378944A1 (en) * 1999-07-23 2001-02-01 Genentech, Inc. Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration
US6747132B2 (en) * 2000-11-29 2004-06-08 Apex Biosciences, Inc. Methods for the synthesis of a modified hemoglobin solution

Also Published As

Publication number Publication date
AR031482A1 (en) 2003-09-24
DE60128945T2 (en) 2008-02-28
EP1335926B1 (en) 2007-06-13
ATE364613T1 (en) 2007-07-15
MY129812A (en) 2007-05-31
US20040076980A1 (en) 2004-04-22
JP4422406B2 (en) 2010-02-24
WO2002042317A3 (en) 2003-02-06
EP1335926A2 (en) 2003-08-20
JP2004514428A (en) 2004-05-20
WO2002042317A2 (en) 2002-05-30
GB0028361D0 (en) 2001-01-03
TWI289142B (en) 2007-11-01
DE60128945D1 (en) 2007-07-26
CA2428885A1 (en) 2002-05-30
ES2287189T3 (en) 2007-12-16

Similar Documents

Publication Publication Date Title
AU2002223841A1 (en) Method of separating extra-chromosomal dna from other cellular components
AU2001294175A1 (en) Method of purifying antibody
AU2001267740A1 (en) Separation method
AU2002322105A1 (en) Method of selective removal of sige alloys
AUPR208000A0 (en) Method of document searching
AUPQ691400A0 (en) Separation of micromolecules
AU2003300296A1 (en) Sorbent and method for the separation of plasmid dna
AU2002359585A1 (en) Method of extracting contaminants from solid matter
AU2002356978A1 (en) Method of separating compound(s) from mixture(s)
AUPR110100A0 (en) Improved separation of macromolecules
EP1394109A4 (en) Method of separating acid
AU2001238616A1 (en) Rapid nucleic acid separation, isolation and purification methods
AU2001237163A1 (en) Wastewater separator and method of using same
AU2001294258A1 (en) Method of purifying plavastatin
AU2000267917A1 (en) Gas separation process
AU2001263836A1 (en) Method of nucleic acid recovery
AU2002232016A1 (en) Method of isolating charged compounds, especially peptides and proteins
AU2002216032A1 (en) Method of analysing microporous material
AU2001268514A1 (en) Method for screening dna binding
AU2001236047A1 (en) Method of separating and purifying protein
AU2002251220A1 (en) Method of separating alleles
AU2003208649A1 (en) Method of extracting, isolating and purifying sesame protein
AUPR506701A0 (en) Deflector for spiral separator, and method of spiral separation
AU2002213695A1 (en) Method of genomic analysis
AU2001294212A1 (en) Method of analyzing nucleic acid